[Mindray Appoints Ms. Fannie Lin Fan as General Counsel SHENZHEN, China, May 23, 2011 /PRNewswire via COMTEX/ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the appointment of Ms. Fannie Lin Fan as General Counsel of the company. Ms. Fan will join Mindray in June 2011, succeeding Mr. Tim]
[Mindray Appoints Ms. Fannie Lin Fan as General Counsel SHENZHEN, China, May 23, 2011 /PRNewswire via COMTEX/ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the appointment of Ms. Fannie Lin Fan as General Counsel of the company. Ms. Fan will join Mindray in June 2011, succeeding Mr. Tim]
[Mindray Appoints Ms.Fannie Lin Fan Generalunsel SHENZHEN, China, May23, 2011 /PRNewswire viaMTEX/ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the appointment of Ms.Fannie Lin Fan Generalunsel of thempany. Ms.Fan will join Mindray in June2011, succeeding Mr.Tim Fitzpatrick, who will step down to pursue other]
[Mindray Appoints Ms.Fannie Lin Fan Generalunsel SHENZHEN, China, May23, 2011 /PRNewswire viaMTEX/ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the appointment of Ms.Fannie Lin Fan Generalunsel of thempany. Ms.Fan will join Mindray in June2011, succeeding Mr.Tim Fitzpatrick, who will step down to pursue other]
[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Michael H. Lan, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer May 23, 2011 EX-32.1 5 v223770_ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Michael H. Lan Chief Financial Officer May 23, 2011 EX-32.2 6 v223770_ex32-2.htm]
[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Michael H. Lan, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer May 23, 2011 EX-32.1 5 v223770_ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Michael H. Lan Chief Financial Officer May 23, 2011 EX-32.2 6 v223770_ex32-2.htm]
[2 TABLE OF CONTENTS PART I Item 1. Identity of Directors, Senior Management and Advisors [5] Item 2. Offer Statistics and Expected Timetable [5] Item 3. Key Information [5] Item 4. Information on the Company [14] Item 4A. Unresolved Staff Comments [21] Item 5. Operating and Financial Review and Prospects [21]] [Significant Subsidiaries of O2MICRO INTERNATIONAL LIMITED 2 2 2 2 2 2 2 2 International Asset Holding Company, a Cayman Islands company] [CERTIFICATION I, Sterling Du, certify that: 1. 2 I have reviewed this annual report on Form 20-F of O 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [CERTIFICATION I, Perry Kuo, certify that: 1. O 2 Micro I have reviewed this annual report on Form 20-F of 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [O2Micro International Limited CERTIFICATION 2 Micro International Limited (the “Company”) on Form 20-F for the (1) (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Sterling Du Chief Executive Officer Perry Kuo Chief Financial Officer and Principal Accounting] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 2 We consent to the incorporation by reference in Registration Statement Nos. 333-12670, 333-12672, 333-98425, 333-101452, 333-107975, 333-116596, 333-132251,333-153436 and 333-162489 on Form S-8 of our reports dated April 29, 2011 relating to the consolidated financial statements of O Deloitte & Touche Taipei, Taiwan Republic of China May 19, 2011]
[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART I.FINANCIAL INFORMATION 4 Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of March 31, 2011 (unaudited) and December 31, 2010 4ndensednsolidated Statements of Operations and Othermprehensiveome (Loss) for the Three Months Ended March 31, 2011 and 2010 (unaudited)] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Michael H. Lan, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Weibing Lu Chief Executive Officer May 23, 2011] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Michael H. Lan Chief Financial Officer May 23, 2011]
[Item 1 Information Contained in this Form 6-K Report]
[MECOX LANE LIMITED Paul Bang Zhang Chief Financial Officer 2]
